PolyProx Therapeutics

PolyProx Therapeutics is a developer of a new type of drug aimed at providing novel therapies for cancer treatment. The company's drugs will utilize novel engineered proteins that can selectively target tumor cells and trigger natural degradation mechanisms within the cells, allowing cancer patients to benefit from targeted therapy and eliminate pathogenic proteins.